Abstract
Background & Aims: postherpetic neuralgia (PHN) is persistent pain more than 3 months after herpes zoster , often requiring multimodal treatment due
to the different underlying mechanisms generating and maintaining the neuralgia, such as sensitization and deafferentiation. To guide drug treatment,
quantitative sensory testing (QST) is a helpful tool to identify clinical phenotypes associated with specific pathophysiological processes paving the way for
precision medicine. However, the time-intensive nature and the costs of QST restricts the applicability in routine clinical practice, highlighting the need for
faster, cost-effective methods to define clinical phenotypes. In this study, we propose and validate a time and cost effective bedside (BS-)tool to identify
patients with a mechanical sensitization phenotype.
Methods: a cross-sectional study was performed in 42 PHN patients of the UMC Utrecht, undergoing laboratory QST based on the DFNS(German Research
Network on Neuropathic Pain)-protocol and consecutively the BS-tool protocol. This included a Bailey Tip Therm, a Semmes-Weinstein 300 grams pinprick
monofilament (assessing temporal summation (TS) and mechanical pain sensitivity (MPS)), and a rubber brush (assessing dynamic mechanical allodynia
(DMA)). The correlation between the QST and BS-tool results were analyzed using Spearman’s rank. Cut-offs for sensitization were based on literature and
expert opinion. A sensitivity-specificity analysis was performed, comparing the results of the BS-tool to QST.
Results: 55% of the patients were female, with a mean age of 70 years (range 27-91). The mean numeric pain rating scale (NPRS) was 5 (SD 2.1). PHN
occurred most commonly in the trigeminal nerve (35.7%) or thoracic dermatomes (54.8%). The BS-tool and QST showed moderate to very strong correlation
on the affected side (DMA: ρ=0.833, MPS: ρ=0.598, MPT: ρ=-0.670, TS: ρ=0.752). Signs of mechanical sensitization were observed in 25 patients (59,5%)
with the BS-tool and in 31 (73.8%) using the QST-tool (p=0.058). Mechanical hypersensitivity rates on the affected side were the same for both tests. Windup or hypersensitivity distant to the injured site were more often identified with QST (QST: 38.1%, BS: 9.5%; p=0.003). The BS-tool had a sensitivity of
74.2% and specificity of 81.8% (AUC=0.780) for any signs of mechanical sensitization. The discriminatory power increased for higher NPRS-scores (NPRS ≥
4: AUC=0.865, NPRS ≥ 7: AUC=0.867), and if patients were not able to discriminate cold (AUC=0.917).
Conclusions: the BS-tool shows good correlation with mechanical QST-variables of the DFNS protocol on the affected side and is able to discriminate
between PHN-patients with and without signs of mechanical sensitization. The discriminatory power improves with peripheral measurements, higher pain
scores and disrupted discrimination for cold.
References:
1. Dworkin, R. H. & Portenoy, R. K. Pain and its persistence in herpes zoster. Pain 67, 241–51 (1996).
2. Finnerup, N. B., Sindrup, S. H. & Jensen, T. S. The evidence for pharmacological treatment of neuropathic pain. Pain 150, 573–581 (2010).
3. Baron, R. et al. Peripheral neuropathic pain: A mechanism-related organizing principle based on sensory profiles. Pain 158, 261–272 (2017).
4. Woolf, C.J. Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management. Annals of Internal Medicine 140, 441–451 (2004).
to the different underlying mechanisms generating and maintaining the neuralgia, such as sensitization and deafferentiation. To guide drug treatment,
quantitative sensory testing (QST) is a helpful tool to identify clinical phenotypes associated with specific pathophysiological processes paving the way for
precision medicine. However, the time-intensive nature and the costs of QST restricts the applicability in routine clinical practice, highlighting the need for
faster, cost-effective methods to define clinical phenotypes. In this study, we propose and validate a time and cost effective bedside (BS-)tool to identify
patients with a mechanical sensitization phenotype.
Methods: a cross-sectional study was performed in 42 PHN patients of the UMC Utrecht, undergoing laboratory QST based on the DFNS(German Research
Network on Neuropathic Pain)-protocol and consecutively the BS-tool protocol. This included a Bailey Tip Therm, a Semmes-Weinstein 300 grams pinprick
monofilament (assessing temporal summation (TS) and mechanical pain sensitivity (MPS)), and a rubber brush (assessing dynamic mechanical allodynia
(DMA)). The correlation between the QST and BS-tool results were analyzed using Spearman’s rank. Cut-offs for sensitization were based on literature and
expert opinion. A sensitivity-specificity analysis was performed, comparing the results of the BS-tool to QST.
Results: 55% of the patients were female, with a mean age of 70 years (range 27-91). The mean numeric pain rating scale (NPRS) was 5 (SD 2.1). PHN
occurred most commonly in the trigeminal nerve (35.7%) or thoracic dermatomes (54.8%). The BS-tool and QST showed moderate to very strong correlation
on the affected side (DMA: ρ=0.833, MPS: ρ=0.598, MPT: ρ=-0.670, TS: ρ=0.752). Signs of mechanical sensitization were observed in 25 patients (59,5%)
with the BS-tool and in 31 (73.8%) using the QST-tool (p=0.058). Mechanical hypersensitivity rates on the affected side were the same for both tests. Windup or hypersensitivity distant to the injured site were more often identified with QST (QST: 38.1%, BS: 9.5%; p=0.003). The BS-tool had a sensitivity of
74.2% and specificity of 81.8% (AUC=0.780) for any signs of mechanical sensitization. The discriminatory power increased for higher NPRS-scores (NPRS ≥
4: AUC=0.865, NPRS ≥ 7: AUC=0.867), and if patients were not able to discriminate cold (AUC=0.917).
Conclusions: the BS-tool shows good correlation with mechanical QST-variables of the DFNS protocol on the affected side and is able to discriminate
between PHN-patients with and without signs of mechanical sensitization. The discriminatory power improves with peripheral measurements, higher pain
scores and disrupted discrimination for cold.
References:
1. Dworkin, R. H. & Portenoy, R. K. Pain and its persistence in herpes zoster. Pain 67, 241–51 (1996).
2. Finnerup, N. B., Sindrup, S. H. & Jensen, T. S. The evidence for pharmacological treatment of neuropathic pain. Pain 150, 573–581 (2010).
3. Baron, R. et al. Peripheral neuropathic pain: A mechanism-related organizing principle based on sensory profiles. Pain 158, 261–272 (2017).
4. Woolf, C.J. Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management. Annals of Internal Medicine 140, 441–451 (2004).
| Original language | English |
|---|---|
| Publication status | Published - 2025 |
| Event | Neupsig 2025 Berlin - Germany, Berlin Duration: 4 Sept 2025 → 6 Sept 2025 |
Conference
| Conference | Neupsig 2025 Berlin |
|---|---|
| City | Berlin |
| Period | 4/09/25 → 6/09/25 |
Fingerprint
Dive into the research topics of 'Validation of a bedside sensory tool for detecting mechanical sensitization'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver